|
|
|
Volumn 2, Issue 1, 2001, Pages 118-122
|
|
SB-271046 SmithKline Beecham
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIMIDINYL]BENZENESULFONAMIDE;
5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE;
ANTICONVULSIVE AGENT;
ANTISENSE OLIGONUCLEOTIDE;
ASPARTIC ACID;
ATROPINE;
CARBAMAZEPINE;
CLOZAPINE;
CYTOCHROME P450;
DOPAMINE;
GLUTAMATE TRANSPORTER;
GLUTAMIC ACID;
HALOPERIDOL;
NORADRENALIN;
PHYSOSTIGMINE;
PROTEIN C FOS;
SB 258585;
SCOPOLAMINE;
SEROTONIN;
SEROTONIN 6 RECEPTOR;
SEROTONIN ANTAGONIST;
TETRODOTOXIN;
UNCLASSIFIED DRUG;
AMINO ACID BRAIN LEVEL;
ANTICONVULSANT ACTIVITY;
BINDING AFFINITY;
CHOLINERGIC SYSTEM;
CLINICAL TRIAL;
COGNITION;
DRUG ANTAGONISM;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG BRAIN LEVEL;
DRUG METABOLISM;
DRUG PENETRATION;
DRUG RECEPTOR BINDING;
DRUG SPECIFICITY;
DRUG SYNTHESIS;
HUMAN;
NERVE DEGENERATION;
NONHUMAN;
RECEPTOR OCCUPANCY;
REVIEW;
SCHIZOPHRENIA;
STRUCTURE ACTIVITY RELATION;
|
|
EID: 0035156322
PISSN: 09678298
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (29)
|
